ACPP antibody (full length)
Quick Overview for ACPP antibody (full length) (ABIN7877601)
Target
See all ACPP AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- ACP3 Antibody / Acid phosphatase 3 / PSAP
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the ACP3 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the ACP3 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the ACP3 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ACPP (Acid Phosphatase, Prostate (ACPP))
-
Alternative Name
- ACP3
-
Background
- Recognizes a protein of 52 kDa, identified as prostate specific acid phosphatase (PSAP) and Acid phosphatase 3 (APC3). This enzyme catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. PSAP is found in non-neoplastic adult and fetal prostatic glands, primary and metastatic prostatic carcinomas. It shows no staining in granulocytes, osteoclasts, parietal cells of the stomach, liver cells, renal cell or breast carcinomas.
-
UniProt
- P15309
-
Pathways
- Synaptic Membrane, Ribonucleoside Biosynthetic Process
Target
-